Structures by: Czerwińska K.
Total: 29
C24H20B,C22H17ClN3OPt,C2H3N
C24H20B,C22H17ClN3OPt,C2H3N
Dalton transactions (Cambridge, England : 2003) (2018) 47, 18 6444-6463
a=7.8085(3)Å b=15.6671(7)Å c=17.1368(5)Å
α=77.338(3)° β=89.736(3)° γ=76.579(4)°
C26H19AuClN3O,2(F6P)
C26H19AuClN3O,2(F6P)
Dalton transactions (Cambridge, England : 2003) (2018) 47, 18 6444-6463
a=8.0750(3)Å b=21.7655(9)Å c=17.4149(6)Å
α=90° β=93.847(3)° γ=90°
C22H17AuClN3O,2(F6P),C2H3N
C22H17AuClN3O,2(F6P),C2H3N
Dalton transactions (Cambridge, England : 2003) (2018) 47, 18 6444-6463
a=15.2102(8)Å b=12.3174(5)Å c=17.3958(6)Å
α=90° β=109.289(5)° γ=90°
C26H19ClN3OPt,CF3O3S
C26H19ClN3OPt,CF3O3S
Dalton transactions (Cambridge, England : 2003) (2018) 47, 18 6444-6463
a=11.8647(7)Å b=14.5225(8)Å c=15.1167(7)Å
α=90° β=94.526(5)° γ=90°
(1S,2R,7S,8aS)-1,2,7-trihydroxy-5,5-dimethyloctahydro-1H-indolizin-4-ium chloride
C10H20NO3,Cl
Organic & biomolecular chemistry (2015) 14, 2 470-482
a=6.82581(5)Å b=12.02340(7)Å c=14.64680(9)Å
α=90° β=90° γ=90°
(R)-2-((tert-butyldimethylsilyl)oxy)-1-((4R,5S)-5-((4S,6S)-2',2'-dimethyl-7-oxa-1-azaspiro[bicyclo[2.2.1]heptane-2,5'-[1,3]dioxan]-6-yl)-2,2-dimethyl-1,3-dioxolan-4-yl)ethanol
C23H43NO7Si
Organic & biomolecular chemistry (2015) 14, 2 470-482
a=7.96665(7)Å b=10.06647(10)Å c=31.8330(3)Å
α=90° β=90° γ=90°
2-((4-phenylpiperazin-1-yl)methyl)phenylboronic acid
C17H21BN2O2
New J. Chem. (2015) 39, 6 4308
a=13.3088(2)Å b=6.01200(10)Å c=19.8330(2)Å
α=90.00° β=108.6467(14)° γ=90.00°
2-((4-(2-methoxyphenyl)piperazin-1-yl)methyl)phenylboronic acid
C18H23BN2O3
New J. Chem. (2015) 39, 6 4308
a=12.1978(3)Å b=19.2053(5)Å c=15.5424(4)Å
α=90.00° β=96.000(3)° γ=90.00°
2-((4-(2,3-dichlorophenyl)piperazin-1-yl)methyl)phenylboronic acid
C17H19BCl2N2O2
New J. Chem. (2015) 39, 6 4308
a=7.9155(4)Å b=10.3130(4)Å c=11.8333(7)Å
α=88.456(4)° β=72.897(5)° γ=69.370(4)°
2-((4-(4-nitrophenyl)piperazin-1-yl)methyl)phenylboronic acid
C17H20BN3O4
New J. Chem. (2015) 39, 6 4308
a=10.32568(6)Å b=9.10656(10)Å c=18.03844(12)Å
α=90.00° β=90.7068(6)° γ=90.00°
2-((4-methylpiperazin-1-yl)methyl)phenylboronic acid
C12H19BN2O2,H2O
New J. Chem. (2015) 39, 6 4308
a=12.87751(17)Å b=10.18562(12)Å c=10.36536(14)Å
α=90.00° β=90.00° γ=90.00°
2-((4-benzhydrylpiperazin-1-yl)methyl)phenylboronic acid
C24H27BN2O2,C3H6O
New J. Chem. (2015) 39, 6 4308
a=24.60371(16)Å b=11.76829(7)Å c=17.52165(11)Å
α=90.00° β=93.8287(6)° γ=90.00°
C10H14CuN6OS2
C10H14CuN6OS2
CrystEngComm (2016) 18, 47 9042
a=18.855(2)Å b=5.6220(4)Å c=16.886(2)Å
α=90° β=121.342(17)° γ=90°
C38H56Cu3N18O2S6
C38H56Cu3N18O2S6
CrystEngComm (2016) 18, 47 9042
a=9.8235(5)Å b=10.5552(6)Å c=15.0423(6)Å
α=77.423(4)° β=79.796(4)° γ=63.616(6)°
C13H9CuN7S2
C13H9CuN7S2
CrystEngComm (2016) 18, 47 9042
a=12.7902(7)Å b=8.3391(3)Å c=15.9931(7)Å
α=90° β=113.001(6)° γ=90°
C25H32Cu2N11S3
C25H32Cu2N11S3
CrystEngComm (2016) 18, 47 9042
a=20.3583(15)Å b=7.8165(4)Å c=21.6675(17)Å
α=90° β=116.100(9)° γ=90°
C21H14Cl2N3Pt,CF3O3S
C21H14Cl2N3Pt,CF3O3S
CrystEngComm (2016) 18, 29 5528
a=7.3698(3)Å b=21.6379(12)Å c=14.5584(7)Å
α=90° β=102.509(4)° γ=90°
C23H15ClN3PtS,CF3O3S
C23H15ClN3PtS,CF3O3S
CrystEngComm (2016) 18, 29 5528
a=16.2788(13)Å b=7.0245(7)Å c=21.716(2)Å
α=90° β=98.966(7)° γ=90°
C21H14BrClN3Pt,CF3O3S
C21H14BrClN3Pt,CF3O3S
CrystEngComm (2016) 18, 29 5528
a=7.4264(4)Å b=21.7744(14)Å c=14.5258(8)Å
α=90° β=102.970(5)° γ=90°
C20H14AuClN4,2(F6P)
C20H14AuClN4,2(F6P)
Dalton transactions (Cambridge, England : 2003) (2017) 46, 10 3381-3392
a=11.7820(4)Å b=14.9666(6)Å c=28.1505(15)Å
α=90° β=90° γ=90°
O-fluorophenylboronic acid
C6H6BFO2
Crystal Growth & Design (2014) 14, 11 5912
a=5.10172(16)Å b=5.55660(17)Å c=22.0587(7)Å
α=90.00° β=94.731(3)° γ=90.00°
O,m-difluorophenylboronic acid
C6H5BF2O2
Crystal Growth & Design (2014) 14, 11 5912
a=8.96573(17)Å b=4.95730(8)Å c=29.7170(5)Å
α=90° β=97.5927(16)° γ=90°
Diorthofluorophenylboronic acid
C6H5BF2O2
Crystal Growth & Design (2014) 14, 11 5912
a=5.02719(16)Å b=5.39423(15)Å c=23.2334(7)Å
α=90.00° β=91.897(3)° γ=90.00°
O,m,p-trifluorophenylboronic acid
C6H4BF3O2
Crystal Growth & Design (2014) 14, 11 5912
a=4.3762(3)Å b=5.0241(3)Å c=15.6401(11)Å
α=96.483(6)° β=94.143(6)° γ=92.835(6)°
O,o,p-trifluorophenylboronic acid
C6H4BF3O2
Crystal Growth & Design (2014) 14, 11 5912
a=5.00301(10)Å b=5.33367(10)Å c=24.2178(4)Å
α=90.00° β=90.2585(17)° γ=90.00°
2,5-difluorophenylboronic acid
C6H5BF2O2
Crystal Growth & Design (2014) 14, 11 5912
a=4.15299(7)Å b=5.11382(9)Å c=30.7324(5)Å
α=90° β=90.0696(14)° γ=90°
2,5-difluorophenylboronic acid
C6H5BF2O2
Crystal Growth & Design (2014) 14, 11 5912
a=4.9578(4)Å b=5.5256(4)Å c=23.484(2)Å
α=90° β=93.974(8)° γ=90°
2,4-difluorophenylboronic acid
C6H5BF2O2
Crystal Growth & Design (2014) 14, 11 5912
a=3.67926(11)Å b=12.2868(4)Å c=14.3179(4)Å
α=90° β=93.057(3)° γ=90°
C20H14AuClN4,2(F6P)
C20H14AuClN4,2(F6P)
Dalton transactions (Cambridge, England : 2003) (2017) 46, 10 3381-3392
a=7.2833(3)Å b=26.6772(10)Å c=13.7648(8)Å
α=90° β=95.968(4)° γ=90°